Cooper Companies | COO - Себестоимость





Себестоимость Изменить Дата
Abbott USD 6.47B 525M 2026-09
Align Technology USD 317.29M 18.53M 2026-09
AtriCure USD 34.98M 3.04M 2026-06
Bausch Health Companies USD 962M 35M 2026-09
Baxter International USD 1.98B 54M 2026-09
Bayer EUR 4.54B 692M 2026-06
Becton, Dickinson and Co. USD 2.67B 108M 2026-06
Boston Scientific USD 1.96B 93M 2026-09
Cooper Companies USD 401.3M 7.5M 2026-06
Dentsply International USD 405M 48M 2026-06
Dexcom USD 478.4M 36.8M 2026-06
Edwards Lifesciences USD 392.4M 29.8M 2026-06
Globus Medical USD 271M 7.41M 2026-06
Haemonetics USD 136.58M 11.56M 2026-06
Inogen USD 39.59M 1.27M 2024-09
Insulet USD 239.1M 6.4M 2026-06
Integra LifeSciences USD 186.73M 2.13M 2026-09
Intuitive Surgical USD 964.4M 32.5M 2026-09
J&J USD 8.08B 80M 2026-09
Medtronic USD 3.83B 26M 2026-06
Merit Medical Systems USD 203.68M 6.6M 2026-06
Novartis USD 3.46B 83M 2026-03
ResMed USD 612.93M 61.26M 2026-06
STAAR Surgical USD 23.81M 855K 2026-06
Steris USD 808.6M 82.7M 2026-06
Stryker USD 2.26B 106M 2026-06
Tandem Diabetes Care USD 109.78M 653K 2026-06
Teleflex USD 238.62M 2.21M 2026-06
Utah Medical Products USD 3.44M 341K 2026-03
Zimmer Biomet Holdings USD 815.9M 77.6M 2026-06